Literature DB >> 20001215

Bolus delivery of mesenchymal stem cells to injured vasculature in the rabbit carotid artery produces a dysfunctional endothelium.

Ciara A O'Shea1, Sean O Hynes, Georgina Shaw, Barbara A Coen, Ailish C Hynes, Jill McMahon, Mary Murphy, Frank Barry, Timothy O'Brien.   

Abstract

Endothelial dysfunction is an important factor in cardiovascular pathology. It has been suggested that pluripotent mesenchymal stem cells (MSCs) may contribute to repair of the endothelium through paracrine pathways. Enhanced re-endothelialization may be associated with a better outcome following angioplasty procedures. We examined the effect of the delivery of MSCs to a denuded vessel in vivo. The right carotid arteries of New Zealand white rabbits were denuded using an uninflated 3-French Fogarty balloon catheter. 1 x 10(5) MSCs in a bolus of 150 microL were then delivered intraluminally and allowed to dwell for 20 min. MSC engraftment was assessed using PKH-26 labeling and transduction with adenoviral reporter genes. Vessels were examined at 2 weeks for levels of endothelialization, as well as for neointimal hyperplasia and vasomotor function. Engraftment of MSCs was noted in the vessel wall following local arterial delivery. Endothelialization was improved following bolus MSC delivery at 2 weeks post-intervention. However, this endothelium is manifestly dysfunctional as indicated by a significant impairment in vasomotor activity and a significant increase in neointimal formation post-bolus delivery. Consistent with the formation of a dysfunctional endothelium, there was a higher rate of vessel occlusions in bolus-treated vessels due to not only predominately thrombosis but also neointimal hyperplasia. Our results suggest that naive MSCs delivered as a bolus to the occluded injured vascular segment generate dysfunctional endothelium presenting a risk of vessel occlusion. Such risks are important and need to be further assessed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20001215     DOI: 10.1089/ten.TEA.2009.0468

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   3.845


  4 in total

1.  Synergism of matrix stiffness and vascular endothelial growth factor on mesenchymal stem cells for vascular endothelial regeneration.

Authors:  Kathryn Wingate; Michael Floren; Yan Tan; Pi Ou Nancy Tseng; Wei Tan
Journal:  Tissue Eng Part A       Date:  2014-05-09       Impact factor: 3.845

2.  Meta-analysis of the effect of mesenchymal stem cell transplantation on vascular remodeling after carotid balloon injury in animal models.

Authors:  Xinxin Ju; Hong Zou; Kejian Liu; Juncang Duan; Shugang Li; Zheng Zhou; Yan Qi; Jin Zhao; Jianming Hu; Lianghai Wang; Wei Jia; Yutao Wei; Yixun Wang; Wenjie Zhang; Lijuan Pang; Feng Li
Journal:  PLoS One       Date:  2015-03-26       Impact factor: 3.240

3.  Human mesenchymal stem cells cultured on silk hydrogels with variable stiffness and growth factor differentiate into mature smooth muscle cell phenotype.

Authors:  Michael Floren; Walter Bonani; Anirudh Dharmarajan; Antonella Motta; Claudio Migliaresi; Wei Tan
Journal:  Acta Biomater       Date:  2015-11-24       Impact factor: 8.947

4.  Topical administration of allogeneic mesenchymal stromal cells seeded in a collagen scaffold augments wound healing and increases angiogenesis in the diabetic rabbit ulcer.

Authors:  Aonghus O'Loughlin; Mangesh Kulkarni; Michael Creane; Erin E Vaughan; Emma Mooney; Georgina Shaw; Mary Murphy; Peter Dockery; Abhay Pandit; Timothy O'Brien
Journal:  Diabetes       Date:  2013-02-19       Impact factor: 9.461

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.